Intercept Pharmaceuticals Price History

ICPTDelisted Stock  USD 10.31  0.16  1.53%   
If you're considering investing in Intercept Stock, it is important to understand the factors that can impact its price. As of today, the current price of Intercept Pharmaceuticals stands at 10.31, as last reported on the 31st of January, with the highest price reaching 10.50 and the lowest price hitting 10.15 during the day. We have found nine technical indicators for Intercept Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please check out Intercept Pharmaceuticals' Accumulation Distribution of 0.0333, day typical price of 10.32, and Daily Balance Of Power of (0.46) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Intercept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ICPT
Based on monthly moving average Intercept Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intercept Pharmaceuticals by adding Intercept Pharmaceuticals to a well-diversified portfolio.

Intercept Pharmaceuticals Stock Price History Chart

There are several ways to analyze Intercept Stock price data. The simplest method is using a basic Intercept candlestick price chart, which shows Intercept Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Intercept Stock Price History Data

OpenHighLowCloseVolume
01/31/2025
 10.47  10.50  10.15  10.31 
07/24/2023 10.47  10.50  10.15  10.31  686,457 
07/21/2023 10.79  10.88  10.39  10.44  727,180 
07/20/2023 10.93  11.07  10.73  10.76  624,907 
07/19/2023 11.27  11.29  10.92  10.92  740,145 
07/18/2023 11.21  11.45  11.10  11.25  502,170 
07/17/2023 11.27  11.60  11.20  11.30  711,851 
07/14/2023 11.38  11.52  11.04  11.29  1,158,298 
07/13/2023 12.00  12.00  11.18  11.40  1,497,172 
07/12/2023 11.40  11.40  11.06  11.15  727,549 
07/11/2023 11.15  11.22  11.00  11.13  829,444 
07/10/2023 11.26  11.29  11.00  11.14  977,619 
07/07/2023 11.50  11.74  11.24  11.30  674,214 
07/06/2023 11.00  11.47  10.89  11.44  1,346,565 
07/05/2023 11.20  11.25  10.87  11.00  1,154,482 
07/03/2023 11.00  11.22  10.98  11.20  496,852 
06/30/2023 11.23  11.64  11.05  11.06  1,257,439 
06/29/2023 11.80  12.17  11.01  11.17  2,125,264 
06/28/2023 11.33  11.53  10.68  10.90  1,503,119 
06/27/2023 11.49  11.71  11.12  11.25  1,007,113 
06/26/2023 11.56  11.97  11.31  11.36  1,205,897 
06/23/2023 11.69  12.00  10.82  11.74  2,774,310 
06/22/2023 11.69  12.04  11.43  11.55  1,104,641 
06/21/2023 11.26  11.80  10.86  11.74  946,389 
06/20/2023 11.86  12.08  11.19  11.23  1,267,172 
06/16/2023 12.05  12.05  11.51  11.80  4,666,635 
06/15/2023 11.96  12.06  11.65  11.82  1,429,453 
06/14/2023 12.24  12.36  11.86  12.04  1,054,683 
06/13/2023 12.00  12.39  11.88  12.26  670,991 
06/12/2023 12.01  12.43  11.63  11.86  1,238,875 
06/09/2023 12.31  12.44  11.82  11.85  1,043,275 
06/08/2023 11.97  12.51  11.92  12.25  1,028,507 
06/07/2023 11.28  12.14  11.25  11.97  1,358,931 
06/06/2023 11.21  11.33  10.83  11.31  1,188,799 
06/05/2023 11.05  11.40  10.97  11.19  1,261,999 
06/02/2023 10.75  11.13  10.61  11.12  1,122,193 
06/01/2023 10.58  10.79  10.25  10.73  1,173,436 
05/31/2023 10.47  11.02  10.27  10.54  1,487,531 
05/30/2023 10.11  10.86  10.10  10.77  1,554,944 
05/26/2023 9.68  10.33  9.57  10.26  1,476,410 
05/25/2023 9.21  9.78  8.89  9.75  1,734,999 
05/24/2023 9.51  9.62  8.82  9.17  1,948,827 
05/23/2023 9.47  10.07  9.19  9.42  2,775,386 
05/22/2023 11.11  11.82  9.21  9.53  9,165,596 
05/19/2023 13.56  13.56  13.56  13.56  9.00 
05/18/2023 13.86  13.86  12.67  13.56  3,370,978 
05/17/2023 12.50  14.78  11.41  13.83  6,460,467 
05/16/2023 16.06  16.36  15.43  16.21  1,057,542 
05/15/2023 16.00  17.18  15.81  16.45  882,024 
05/12/2023 15.70  16.42  15.51  15.89  562,298 
05/11/2023 15.88  16.05  15.56  15.62  482,862 
05/10/2023 16.08  16.18  15.34  15.90  695,704 
05/09/2023 15.95  15.98  15.56  15.77  525,182 
05/08/2023 16.14  16.40  15.96  16.04  502,741 
05/05/2023 16.34  16.74  16.07  16.16  495,137 
05/04/2023 16.14  16.16  15.60  15.98  437,664 
05/03/2023 16.04  16.57  15.85  16.22  709,960 
05/02/2023 17.07  17.07  15.62  15.65  862,142 
05/01/2023 17.20  17.77  16.87  17.07  664,942 
04/28/2023 16.68  18.03  16.43  17.32  1,221,303 
04/27/2023 17.57  17.64  14.76  15.97  1,839,080 

About Intercept Pharmaceuticals Stock history

Intercept Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intercept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intercept Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intercept Pharmaceuticals stock prices may prove useful in developing a viable investing in Intercept Pharmaceuticals
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company was incorporated in 2002 and is headquartered in New York, New York. Intercept Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.

Intercept Pharmaceuticals Stock Technical Analysis

Intercept Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Intercept Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Intercept Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Intercept Stock

If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios